At the National Conference of the state health insurance bureau, there are new trends in the adjustment of the medical insurance catalogue and the purchase with quantity!

Last Friday (January 10), the National Health Insurance Bureau held a "national health insurance working conference" in Beijing, which laid out the focus and future development direction of health insurance in 2020 The focus topic most concerned by the pharmaceutical industry - volume purchasing and the adjustment of medical insurance catalog has also been mentioned According to the official wechat public platform of the State Medical Insurance Bureau, in 2020, the pilot of centralized drug purchasing organized by the state will be expanded nationwide, and the volume purchasing of drugs and medical consumables will be guided everywhere Formulate a new version of the medical insurance drug catalog, adhere to synchronous transfer out and transfer in, and continuously optimize the drug structure of the catalog Then, more details of policies on two topics, volume purchasing and medical insurance catalogue, were announced in the medical circle Adjustment of medical insurance Catalogue: normalization and fine-tuning are related to the adjustment of medical insurance catalogue According to the news of medical circle, the meeting pointed out that "management measures for medical insurance drugs" will be issued in 2020 to pave the way for the future dynamic adjustment of medical insurance catalogue In the future, the adjustment of medical insurance catalogue will become a regular, timely and normalized fine adjustment It depends on the spirit of the two sessions In the future, the key words of "regular, timely and normalized fine-tuning" in the medical insurance catalogue deserve special attention On January 1, 2020, the latest version of the medical insurance catalog officially began to be implemented, and through regular access and negotiation access, 2709 drugs were included in the national basic medical insurance, work injury insurance and maternity insurance drug catalog in 2019 Compared with 2017 edition, 218 drugs were transferred in, 154 drugs were transferred out, a net increase of 64 According to the criteria of this national health insurance bureau, this large-scale adjustment of medical insurance catalogue will be less and less in the future For innovative drugs, this means that there is no need to wait for a window period, as long as it can solve the disease needs of the people, and within the scope of medical insurance, the door of national medical insurance may be open to you at any time, and there may be more and more ways of negotiation and access in the future In addition, the management of Medicare drugs is particularly noteworthy In September 2019, the state health insurance bureau also mentioned this issue in the letter on the reply to the proposal No 3015 (medical and sports No 327) of the second session of the 13th National Committee of the CPPCC The proposal suggests unifying the payment standard of medical insurance, unifying the national medical insurance catalogue step by step, and reducing the difference of medical treatment in different places In response, the National Medical Insurance Bureau said that because the national medical insurance catalogue is not unified, in order to facilitate the insured people to cross provincial medical treatment, facilitate the doctors to provide medical services according to the management regulations of medical insurance in different places, the cross provincial medical treatment direct settlement work adopts "the insured place to wait for medical treatment" In case of the policy of "directory of medical places", it is inevitable that there is a problem of poor treatment In order to solve these problems, the state health insurance bureau is currently studying and revising the measures for the administration of the scope of drugs used in the national basic medical insurance, establishing and improving the dynamic adjustment mechanism of the medical insurance catalogue, and further standardizing the adjustment of the medical insurance catalogue But now the door of local supplement has been closed, and the national unification of medical insurance catalogue will be realized within three years (the State Medical Insurance Bureau stipulates that the provincial supplement needs to be abolished within three years) In the future, which varieties, especially how innovative varieties enter the medical insurance, and how to improve the security within the scope of medical insurance affordability deserve further attention In addition, the meeting also revealed that "opinions on deepening the reform of medical security system" will be issued before the two sessions The opinion will be issued directly by the CPC Central Committee, which is the highest and most important document in the history of Chinese medical insurance The development direction of the medical insurance system in the next decade will be covered in this opinion In 2020, as a strong buyer, the national health insurance bureau should pay more attention to the purchase logic and the construction of the purchase pattern The belt purchase has been promoted for 3 years In the future, more than 160 varieties will be purchased this Friday, and the second wheel belt purchase will be carried out soon As a heavy policy to end the high profits of expired original research drugs and domestic generic drugs, its specific progress has also been the focus of the industry In Friday's meeting, a message from the medical circle said that in the future, the National Health Insurance Bureau will take centralized procurement as a breakthrough of the three medical linkage reform In the future, the State Council will formulate policies and the state health insurance bureau will implement them The national goal is to focus on the top 160 varieties of hospital procurement from high to low It is planned to carry out another three years and another five to six batches Considering that there are at least 25 varieties in each batch, mainly for those passing the consistency evaluation, at least three imitations of each variety will automatically start the national centralized purchase Other unqualified varieties will be purchased by local organizations According to the statistics of the science and Technology Development Center under the China Pharmaceutical Association, in the first half of 2019, the total number of generic name level varieties of sample hospitals was 2145 From the perspective of hospital level, the total number of total drugs used in tertiary hospitals is 2122, and the total number of total drugs used in secondary and lower hospitals is 1888 In addition to the 55 varieties that have been purchased with quantity, the quantity of products purchased with quantity is about 210, accounting for about 10% of the total quantity of drugs used in hospitals But the selection principles of more than 210 varieties: first, according to the purchase amount of the hospital, from high to low; second, there are more than three imitations that have been evaluated for consistency The sales volume is high, unless the generic process is particularly complex, the second condition is quite simple to achieve, so in addition to traditional Chinese medicine, as long as the sales volume is high, or it is difficult to avoid being brought to purchase.